Medicare Enrolled

Dr. Ana Flanagan, MD

Name: Federal CMS public records for Dr. Ana Flanagan (NPI 1780962100)
Creator: U.S. Centers for Medicare & Medicaid Services
License: https://www.usa.gov/government-works

Family Medicine · Houston, TX

Low-engagement

8225 BROADWAY ST, Houston, TX 77061

7134694735

In practice since 2011 (14 years)

NPI: 1780962100 verify on NPPES ↗

High

DATA COVERAGE

Data in 3 of 4 federal sources

Measures public federal data availability — not provider quality

Informational, not a quality rating. This page presents federal public records about Dr. Flanagan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →

Are you Dr. Flanagan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Flanagan

Dr. Ana Flanagan is a family medicine in Houston, TX, with 14 years in practice.

Between the years covered by Open Payments, Dr. Flanagan received a total of $692 from 9 pharmaceutical and/or device companies across 14 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Flanagan is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice$ $692 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗

$692

Total received (2019-2024)

Avg $173/year across 4 years

Top 44% in TX for family medicine

Companies

Individual payments

All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel

Food, beverages, travel, and lodging — typically low-value

$653 (94.4%)

Consulting

Expert advisory fees, typically reflecting recognized clinical expertise

$39 (5.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024

$80

2021

$35

2020

$267

2019

$310

Payments by company (2024)

Consulting

Speaking

Meals & Travel

Research

GM Pharmaceuticals, Inc.

$495

SANOFI PASTEUR INC.

$39

Genentech USA, Inc.

$35

Otsuka America Pharmaceutical, Inc.

$32

Amarin Pharma Inc.

$29

Novo Nordisk Inc

$19

AstraZeneca Pharmaceuticals LP

$16

Merck Sharp & Dohme Corporation

$14

Bayer Healthcare Pharmaceuticals Inc.

$13

Top 3 companies account for 82.3% of total payments

Associated products mentioned in payments ›

FARXIGA · Kerendia · NO PRODUCT DISCUSSED · Ozempic · PENTACEL · REXULTI · ROTATEQ · Vanacof · Vascepa · Xofluza

Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a family medicine in Houston?
Compare family medicines in the Houston area by procedure volume, costs, and industry payment transparency.

Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi

1,552

Per 100K population

32.6

County median income

$73,104

Nearest hospital

HCA HOUSTON HEALTHCARE SOUTHEAST
5.2 mi

Data Sources

Provider Registry	✓ NPPES	Weekly updates
Medicare Enrollment	✓ PECOS	Monthly updates
Practice Data	— No data	N/A
Industry Payments	✓ Open Payments	CY 2024
Disciplinary History	— Not public	N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Flanagan is a family medicine, and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Flanagan receive payments from pharmaceutical companies?

Yes. Dr. Flanagan received a total of $692 from 9 companies across 14 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

What does Data Coverage mean?

Data Coverage (currently High for Dr. Flanagan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →

Is this data up to date?

Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide

Understanding Family Medicine

Common procedures, typical costs, and what industry payments mean in family medicine.

Same specialty & city

Family Medicines in Houston

Browse family medicines in Houston ranked by procedure volume and transparency data.

Highest volume

Top Family Medicines in TX

Family Medicines ranked by total Medicare services performed statewide.

Industry payments

Pharma Payments to Family Medicines in TX

Which TX family medicines receive the most from drug and device companies.

By company

GM Pharmaceuticals, Inc. Payments to Doctors

See all physicians who received payments from GM Pharmaceuticals, Inc..

By company

SANOFI PASTEUR INC. Payments to Doctors

See all physicians who received payments from SANOFI PASTEUR INC..

By company

Genentech USA, Inc. Payments to Doctors

See all physicians who received payments from Genentech USA, Inc..

About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology